Products for Research Use Only
RegisterLogin

NLG919

CAT: 0498-bs-82923C-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0498-bs-82923C-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
NLG919 (1402836-58-1) is a potent IDO-pathway inhibitor (Ki = 7nM; EC50 = 75nM) .1 It synergizes with chemo-radiation therapy to promote T cell dependent complement deposition in a murine model of glioblastoma.2 In combination with paclitaxel in a mouse B16-F10 melanoma model, NLG919 increased the percentage of CD3+, CD8+, and CD4+ T cells and secretion of IFN-γ and interleukin-2 while decreasing the percentage of CD4+CD25+ regulatory T cells.3
Conjugation
Unconjugated
Buffer
White solid
Storage Conditions
-20°C

Related Products

CatalogName
bs-6721R-01NLG1 Polyclonal Antibody
bs-6721R-TRNLG1 Polyclonal Antibody
BSKR65827-01Rat Neuroligin 1 (NLGN1) ELISA Kit
bs-6721R-RBITCNLG1 Polyclonal Antibody, RBITC Conjugated
bs-6721R-HRPNLG1 Polyclonal Antibody, HRP Conjugated
bs-6721R-PerCPNLG1 Polyclonal Antibody, PerCP Conjugated
bs-6721R-Cy5NLG1 Polyclonal Antibody, Cy5 Conjugated
bs-6721R-Cy7NLG1 Polyclonal Antibody, Cy7 Conjugated
bs-6721R-Cy3NLG1 Polyclonal Antibody, Cy3 Conjugated
bs-6721R-BiotinNLG1 Polyclonal Antibody, Biotin Conjugated

Alternative Products

CatalogName
MBS385794-01NLG919
460821-01NLG919-d10
A14322-10NLG919 10mg
A14322-500NLG919 500mg
A14322-100NLG919 100mg
A14322-25NLG919 25mg
A14322-50NLG919 50mg
A14322-5NLG919 5mg
A14322-2NLG919 2mg
206165NLG919 (GDC-0919)

Popular Products